Inventor
LEE JOHN C
US37 patents
⚠️ This page may combine multiple inventors who share the name “LEE JOHN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM CORP
14 patentsUS5686455ANov 11, 1997
Imidazole derivatives and their use as cytokine inhibitors
SMITHKLINE BEECHAM CORP205 citations99
US5656644AAug 12, 1997
Pyridyl imidazoles
SMITHKLINE BEECHAM CORP224 citations99
US6645989B2Nov 11, 2003
Compounds
SMITHKLINE BEECHAM CORP91 citations98
US6268370B1Jul 31, 2001
Compounds
SMITHKLINE BEECHAM CORP106 citations98
US5777097AJul 7, 1998
Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein
SMITHKLINE BEECHAM CORP96 citations98
US5871934AFeb 16, 1999
Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins
SMITHKLINE BEECHAM CORP96 citations97
US5916891AJun 29, 1999
Pyrimidinyl imidazoles
SMITHKLINE BEECHAM CORP63 citations96
US5955366ASep 21, 1999
Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins
SMITHKLINE BEECHAM CORP46 citations95
US5783664AJul 21, 1998
Cytokine suppressive anit-inflammatory drug binding proteins
SMITHKLINE BEECHAM CORP86 citations95
US5317019AMay 31, 1994
Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
SMITHKLINE BEECHAM CORP70 citations93
US6361773B1Mar 26, 2002
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
SMITHKLINE BEECHAM CORP21 citations92
US5969184AOct 19, 1999
Amide compounds
SMITHKLINE BEECHAM CORP31 citations92
US6150557ANov 21, 2000
Compounds
SMITHKLINE BEECHAM CORP8 citations73
US6103936AAug 15, 2000
Process of making tosylbenzyl formamide derivatives
SMITHKLINE BEECHAM CORP2 citations61
STRYKER CORP
8 patentsUS6048964AApr 11, 2000
Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
STRYKER CORP227 citations98
US5948428ASep 7, 1999
Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
STRYKER CORP342 citations98
US5916870AJun 29, 1999
Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
STRYKER CORP302 citations98
US5854207ADec 29, 1998
Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
STRYKER CORP257 citations98
US7026292B1Apr 11, 2006
Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
STRYKER CORP36 citations92
US6696410B1Feb 24, 2004
Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
STRYKER CORP11 citations73
US6987021B2Jan 17, 2006
Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
STRYKER CORP0 citations51
US6368787B1Apr 9, 2002
Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
STRYKER CORP1 citations51
LEE JOHN C
4 patentsUS4342259AAug 3, 1982
Cooking grill
LEE JOHN C33 citations92
US8934911B2Jan 13, 2015
Cellular communication system comprising macro and micro cells
LEE JOHN C4 citations72
US8514730B2Aug 20, 2013
Telecommunications routing
LEE JOHN C6 citations72
US8483126B2Jul 9, 2013
Multi-network mobile communications systems and/or methods
LEE JOHN C0 citations39
SMITHKLINE BECKMAN CORP
3 patentsUS4794114ADec 27, 1988
Inhibition of interleukin-1 production by monocytes and/or macrophages
SMITHKLINE BECKMAN CORP37 citations92
US4780470AOct 25, 1988
Inhibition of interleukin-1 by monocytes and/or macrophages
SMITHKLINE BECKMAN CORP16 citations73
US4778806AOct 18, 1988
Inhibition of interleukin-1 production by monocytes and/or macrophages
SMITHKLINE BECKMAN CORP15 citations73